Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for receptor interacting protein
Most Correlated Studies
- Human umbilical vein endothelial cells (HUVECs) adhering to soluble VEGFR1 or fibronectin
- Cerebrocortical cells treated with blood-brain barrier penetrant clinic-tested drugs
- Melanoma cell line treated with MEK and PI3K/mTOR inhibitors
- Hepatoma Hep 3B cells serum starved and treated with combinations of BMP2, BMP6, Noggin, RGMc
- Marginal zone macrophages with IFNAR1 knockout or treated with sLTβR-Fc
Most Relevant Literature
- RIPK1 activation mediates neuroinflammation and disease progression in multiple sclerosis.
- Primidone blocks RIPK1-driven cell death and inflammation.
- RIPK1-RIPK3 mediates myocardial fibrosis in type 2 diabetes mellitus by impairing autophagic flux of…
- TAB2 deficiency induces dilated cardiomyopathy by promoting RIPK1-dependent apoptosis and necroptosi…
- Design, synthesis, and evaluation of potent RIPK1 inhibitors with in vivo anti-inflammatory activity…
Most Relevant Clinical Trials
- Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene Mutations in Acromegaly
- PUSH Plus Protein Pilot for Hip Fracture Patients
- Interaction Between HIV and Platelets
- Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patien…
- Effect of Dietary Protein on the Regulation of Exosome microRNA Expression in Patients With Insulin …
